Tabassum Asif Khan (Tabassum Khan)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Chemical biology & drug design

Antibiotics (Basel, Switzerland)

Molecules (Basel, Switzerland)

Dermatologic therapy

Dr Bhanuben Nanavati College of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dr Bhanuben Nanavati College of Pharmacy

India

Professor & HOD :: Pharmaceutical Chemistry & Quality Assurance

Publications

Sahaya Nadar, Maheshkumar R Borkar, Tabassum Asif Khan
Identification of potential focal adhesion kinase (FAK) inhibitors: a molecular modeling approach. Journal of biomolecular structure & dynamics (2024)
Vasanti Suvarna, Rashmi Mallya, Kajal Deshmukh, Bhakti Sawant, Tabassum Asif Khan, Abdelwahab Omri
Novel vesicular bilosomal delivery systems for dermal/transdermal applications. Current drug delivery (2023)
Vasanti Suvarna, Arya Nair, Rashmi Mallya, Tabassum Asif Khan, Abdelwahab Omri
Antimicrobial Nanomaterials for Food Packaging. Antibiotics (Basel, Switzerland) 11 (6) (2022)
Prabha Singh, Pramita Waghambare, Tabassum Asif Khan, Abdelwahab Omri
Colorectal cancer management: strategies in drug delivery. Expert opinion on drug delivery 19 (6) (2022)
Sahaya Nadar, Tabassum Asif Khan, Simon G Patching, Abdelwahab Omri
Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance. Microorganisms 10 (2) (2022)
Arya Nair, Rashmi Mallya, Vasanti Suvarna, Tabassum Asif Khan, Munira Momin, Abdelwahab Omri
Nanoparticles-Attractive Carriers of Antimicrobial Essential Oils. Antibiotics (Basel, Switzerland) 11 (1) (2022)
Palak Jethva, Munira Momin, Tabassum Asif Khan, Abdelwahab Omri
Lanthanide-Doped Upconversion Luminescent Nanoparticles-Evolving Role in Bioimaging, Biosensing, and Drug Delivery. Materials (Basel, Switzerland) 15 (7) (2022)
Sahaya Nadar, Tabassum Asif Khan, Abdelwahab Omri
Reemergence of monkeypox: prevention and management. Expert review of anti-infective therapy 20 (11) (2022)
Sahaya Nadar, Tabassum Asif Khan
Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity. Chemical biology & drug design 100 (6) (2021)
Sahil Butala, Vasanti Suvarna, Rashmi Mallya, Tabassum Asif Khan
An insight into cytotoxic activity of flavonoids and sesquiterpenoids from selected plants of Asteraceae species. Chemical biology & drug design 98 (6) (2021)
Kaksha Sankhe, Arati Prabhu, Tabassum Asif Khan
Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer. Chemical biology & drug design 98 (1) (2021)
Mrunal Jadhav, Kaksha Sankhe, Richie R Bhandare, Zehra Edis, Samir Haj Bloukh, Tabassum Asif Khan
Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors. Molecules (Basel, Switzerland) 26 (17) (2021)
Akshita Chauhan, Tabassum Asif Khan, Abdelwahab Omri
Design and Encapsulation of Immunomodulators onto Gold Nanoparticles in Cancer Immunotherapy. International journal of molecular sciences 22 (15) (2021)
Jhanvi Jhaveri, Zarna Raichura, Tabassum Asif Khan, Munira Momin, Abdelwahab Omri
Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics. Molecules (Basel, Switzerland) 26 (2) (2021)
Akshita Chauhan, Tabassum Asif Khan
Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors. Chemical biology & drug design 97 (3) (2020)
Omkar Sawant, Tabassum Asif Khan
Management of periorbital hyperpigmentation: An overview of nature-based agents and alternative approaches. Dermatologic therapy 33 (4) (2020)

Tabassum Asif Khan.css-eqlu8i{font-size:small;padding-left:4px;} (Tabassum Khan)

Publication Activity (10 Years)

Top Topics

Top Venues

Tabassum Asif Khan (Tabassum Khan)